Kumar Prabhash
Impact in
- Otorhinolaryngology top 0.1%
- Head and Neck Cancer Studies
- Oncology top 0.5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
-
- Head and Neck Cancer Studies 143
-
- Lung Cancer Treatments and Mutations 151
- Lung Cancer Diagnosis and Treatment 59
- Brain Metastases and Treatment 25
- Co-authors
- Vanita Noronha (251 shared papers)Amit Joshi (158 shared papers)Vijay Patil (179 shared papers)Amit Joshi (110 shared papers)Anil Keith Dcruz (25 shared papers)Nandini Sharrel Menon (104 shared papers)Vedang Murthy (25 shared papers)Abhishek Mahajan (96 shared papers)
- Journals
- Annals of Oncology (26 papers)Oral Oncology (24 papers)Clinical Oncology (19 papers)Journal of Clinical Oncology (14 papers)JCO Global Oncology (11 papers)
- Partner nations
- IndiaUnited StatesUnited Kingdom
In The Last Decade
Kumar Prabhash
588 papers receiving 9.7k citations
Kumar Prabhash's Hit Papers
Peers
Comparison fields: 5 of 148
- Otorhinolaryngology 1.8k
- Oncology 3.4k
- Pulmonary and Respiratory Medicine 3.8k
- Geriatrics and Gerontology 207
- Cancer Research 866
Countries citing papers authored by Kumar Prabhash
This map shows the geographic impact of Kumar Prabhash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kumar Prabhash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kumar Prabhash more than expected).
Fields of papers citing papers by Kumar Prabhash
This network shows the impact of papers produced by Kumar Prabhash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kumar Prabhash. The network helps show where Kumar Prabhash may publish in the future.
Co-authors
The 25 scholars most cited alongside Kumar Prabhash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 640 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial Hit paper breakdown → | 2014 | 1049 |
| 2 | Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR -Mutated Lung Cancer Hit paper breakdown → | 2019 | 345 |
| 3 | 2012 | 286 | |
| 4 | Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial Hit paper breakdown → | 2017 | 259 |
| 5 | 2012 | 259 | |
| 6 | Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC Hit paper breakdown → | 2024 | 250 |
| 7 | Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial Hit paper breakdown → | 2021 | 233 |
| 8 | 2016 | 150 | |
| 9 | Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study Hit paper breakdown → | 2022 | 142 |
| 10 | 2013 | 139 | |
| 11 | 2012 | 136 | |
| 12 | 2017 | 135 | |
| 13 | 2018 | 129 | |
| 14 | 2014 | 115 | |
| 15 | 2015 | 114 | |
| 16 | 2023 | 109 | |
| 17 | 2013 | 103 | |
| 18 | 2019 | 96 | |
| 19 | 2019 | 87 | |
| 20 | 2021 | 85 |
About Kumar Prabhash
Kumar Prabhash is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine, Oncology, Surgery and Cancer Research, having authored 640 papers that have together received 10.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (151 papers), Head and Neck Cancer Studies (143 papers), Lung Cancer Diagnosis and Treatment (59 papers), Lung Cancer Research Studies (48 papers), Cancer Genomics and Diagnostics (37 papers), Head and Neck Surgical Oncology (32 papers), Cancer Immunotherapy and Biomarkers (31 papers) and Brain Metastases and Treatment (25 papers). The work is most often cited by research in Otorhinolaryngology (1.8k citations), Oncology (3.4k citations), Pulmonary and Respiratory Medicine (3.8k citations), Geriatrics and Gerontology (207 citations) and Cancer Research (866 citations). Kumar Prabhash has collaborated with scholars based in India, United States and United Kingdom. Frequent co-authors include Vanita Noronha, Amit Joshi, Vijay Patil, Amit Joshi, Anil Keith Dcruz, Nandini Sharrel Menon, Vedang Murthy, Abhishek Mahajan, Sarbani Ghosh Laskar and Sachin Babanrao Dhumal. Their work appears in journals such as Annals of Oncology, Oral Oncology, Clinical Oncology, Journal of Clinical Oncology and JCO Global Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.